Regulon

Regulon: R-2209

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
150.15606710Pr-132Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
8540 ENSG00000018510 AGPS O00116
9967 ENSG00000054118 THRAP3 Q9Y2W1
2936 ENSG00000104687 GSR P00390
23530 ENSG00000112992 NNT Q13423
81537 ENSG00000126821 SGPP1 Q9BX95
23039 ENSG00000130227 XPO7 Q9UIA9
10277 ENSG00000130939 UBE4B O95155
9475 ENSG00000134318 ROCK2 O75116
102 ENSG00000137845 ADAM10 O14672
29766 ENSG00000138594 TMOD3 Q9NYL9
9908 ENSG00000138757 G3BP2 D6R9A4
10146 ENSG00000145907 G3BP1 E5RJU8
2776 ENSG00000156052 GNAQ P50148
114791 ENSG00000280807 TUBGCP5 Q96RT8
64087 ENSG00000281742 MCCC2 Q9HCC0

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
BELUMOSUDIL MESYLATEROCK2Small moleculeINHIBITORRho-associated protein kinase inhibitor40
NETARSUDIL DIMESYLATEROCK2Small moleculeINHIBITORRho-associated protein kinase inhibitor40
CARMUSTINEGSRSmall moleculeINHIBITORGlutathione reductase inhibitor44
BELUMOSUDILROCK2Small moleculeINHIBITORRho-associated protein kinase inhibitor40
NETARSUDILROCK2Small moleculeINHIBITORRho-associated protein kinase inhibitor40
FASUDILROCK2Small moleculeINHIBITORRho-associated protein kinase inhibitor30
AMA0076ROCK2Small moleculeINHIBITORRho-associated protein kinase inhibitor20
AT-13148MAPKAPK2Small moleculeINHIBITORRho-associated protein kinase inhibitor10
OXIGLUTATIONEGSRSmall moleculeOTHERGlutathione reductase40
DE-104ROCK2Small moleculeINHIBITORRho-associated protein kinase inhibitor20
SAR-407899ROCK2Small moleculeINHIBITORRho-associated protein kinase inhibitor20
VEROSUDILROCK2Small moleculeINHIBITORRho-associated protein kinase inhibitor20

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-2209

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs